Filter by
Filter results


Report series

All publications


All miscellaneous
65 results found
Blog |
26 January 2020

We’re all still waiting, Gilead ...

One year after the pharmaceutical corporation Gilead Sciences promised lower prices for a key drug for people with advanced HIV, why are people still waiting for this lifesaving treatment? Jess Burry, a pharmacist in the Access Campaign, asks if Gilead’s promise is just one big PR stunt.